137 results

A combination of Shire and Baxalta would add to the more than $600 billion in healthcare merger deals this year, which has been the busiest in the history of healthcare deal making

Dublin-based drug maker Shire has made a new acquisition offer for peer Baxalta International that is roughly in line with the latter’s valuation expe(...)

Ryanair rose by 3.2 per cent after a strong set of results in the six months to the end of September. Photograph: Andy Rain/EPA

The Iseq rose by 1.1 per cent as European shares had a positive start to the week after business surveys from around the euro zone beat expectations.(...)

Pharmaceutical firm Shire said it was still pursuing its attempt to buy US company Baxalta as it posted a 11 percent rise in third-quarter earnings pe(...)

Wolseley led the drop, falling 12.5 per cent, after it forecast North American industrial markets will be challenging, and the UK heating industry will remain competitive. Photograph: Anna Gowthorpe/PA Wire

Financial markets remained on edge after a rout Monday, as a rally in US stocks faded while gauges of European and emerging-market equities retreated.(...)

Flemming Ornskov, chief executive officer of Shire: has spent much of the past two weeks pressing his company’s case to buy Baxalta. Photograph: Chris Ratcliffe/Bloomberg

Shire is stepping up pressure on Baxalta to open its books before the Dublin drugmaker will consider making a higher offer as it tries to break the de(...)

Flemming Ornskov, chief executive of Shire. Photographer: Chris Ratcliffe/Bloomberg

Shire chief executive Flemming Ornskov is stepping up his campaign to get Baxalta to the negotiating table as he pushes the benefits a $30 billion t(...)

Apple weighed heavily on all major US stock indices as it fell for the fifth straight day. Photograph: Kimihiro Hoshino/AFP/Getty Images

Greece’s banking stocks plunged for the second day in a row, holding down the main Athens index which otherwise turned the corner after the previous (...)

Dublin-based Shire was itself the target of a failed $50 billion takeover attempt by AbbVie last year.

Drugmaker Shire said on Tuesday it was seeking to buy Baxalta, a company spun-off by Baxter International last month, for $30 billion (€27.35 billion)(...)

Guinness owner Diageo is reportedly being eyed up by Brazilian billionaire Jorge Paulo Lemann and his partners in private equity firm 3G Capital. (Photograph: Eric Luke / The Irish Times)

European shares fell on Monday, weighed down by a drop in agrochemicals group Syngenta although Deutsche Bank outperformed to surge higher after boar(...)

 Shares in Actelion, Europe’s biggest biotech company, jumped 7 per cent to a record high on Monday after a report Shire was considering a $18 billion takeover. Photo: Bloomberg

Shares in Actelion, Europe’s biggest biotech company, jumped 7 per cent to a record high on Monday after a report Shire was considering a $18 billion (...)

  • « First
  • Prev
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • Next
  • Last »